Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does tertiary Gleason score 5 have prognostic significance in men with prostate cancer?

Nature Clinical Practice Urology volume 5, pages 250–251 (2008)Cite this article

boxed-textPatel AA et al. (2007) PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5. JAMA 298: 1533–1538

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50: 125–128

    CAS  PubMed  Google Scholar 

  2. Mosse CA et al. (2004) The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens. Am J Surg Pathol 28: 394–398

    Article  Google Scholar 

  3. Epstein JI et al. (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29: 1228–1242

    Article  Google Scholar 

  4. Partin AW et al. (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277: 1445–1451

    Article  CAS  Google Scholar 

  5. Di Blasio CJ et al. (2003) Predicting clinical end points: treatment nomograms in prostate cancer. Semin Oncol 30: 567–586

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Johns Hopkins Hospital, 401 N. Broadway Street, Rm 2242, Baltimore, MD 21231, USA jepstein@jhmi.edu

Authors and Affiliations

  1. JI Epstein is a Professor in the Departments of Pathology, and Director of Surgical Pathology in the Department of Pathology at Johns Hopkins Hospital, Urology and Oncology, the Reinhard Professor of Urologic Pathology at Johns Hopkins Medical Institutions, Baltimore, MD, USA.,

    Jonathan I Epstein

Authors
  1. Jonathan I Epstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Epstein, J. Does tertiary Gleason score 5 have prognostic significance in men with prostate cancer?. Nat Rev Urol 5, 250–251 (2008). https://doi.org/10.1038/ncpuro1099

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro1099

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing